Cargando…

CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS

Back pain is a leading cause of global disability associated with intervertebral disc (IVD) pathologies. Discectomy alleviates disabling pain caused by IVD herniation without repairing annulus fibrosus (AF) defects, which can cause accelerated degeneration and recurrent pain. Biological therapies sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Panebianco, C.J., DiStefano, T.J., Mui, B., Hom, W.W., Iatridis, J.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372750/
https://www.ncbi.nlm.nih.gov/pubmed/32396210
http://dx.doi.org/10.22203/eCM.v039a14
_version_ 1783561373227155456
author Panebianco, C.J.
DiStefano, T.J.
Mui, B.
Hom, W.W.
Iatridis, J.C.
author_facet Panebianco, C.J.
DiStefano, T.J.
Mui, B.
Hom, W.W.
Iatridis, J.C.
author_sort Panebianco, C.J.
collection PubMed
description Back pain is a leading cause of global disability associated with intervertebral disc (IVD) pathologies. Discectomy alleviates disabling pain caused by IVD herniation without repairing annulus fibrosus (AF) defects, which can cause accelerated degeneration and recurrent pain. Biological therapies show promise for IVD repair but developing high-modulus biomaterials capable of providing biomechanical stabilisation and delivering biologics remains an unmet challenge. The present study identified critical factors and developed an optimal formulation to enhance the delivery of AF cells and transforming growth factor beta-3 (TGFβ−3) in genipin-crosslinked fibrin (FibGen) hydrogels. Part 1 showed that AF cells encapsulated in TGFβ−3-supplemented high-modulus FibGen synthesised little extracellular matrix (ECM) but could release TGFβ−3 at physiologically relevant levels. Part 2 showed that AF cells underwent apoptosis when encapsulated in FibGen, even after reducing fibrin concentration from 70 to 5 mg/mL. Mechanistic experiments, modifying genipin concentration and integrin binding site presence demonstrated that genipin crosslinking caused AF cell apoptosis by inhibiting cell-biomaterial binding. Adding integrin binding sites with fibronectin partially rescued apoptosis, indicating genipin also caused acute cytotoxicity. Part 3 showed that FibGen formulations with 1 mg/mL genipin had enhanced ECM synthesis when supplemented with fibronectin and TGFβ−3. In conclusion, FibGen could be used for delivering biologically active compounds and AF cells, provided that formulations supplied additional sites for cell-biomaterial binding and genipin concentrations were low. Results also highlighted a need for developing strategies that protect cells against acute crosslinker cytotoxicity to overcome challenges of engineering high-modulus cell carriers for musculoskeletal tissues that experience high mechanical demands.
format Online
Article
Text
id pubmed-7372750
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-73727502020-07-21 CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS Panebianco, C.J. DiStefano, T.J. Mui, B. Hom, W.W. Iatridis, J.C. Eur Cell Mater Article Back pain is a leading cause of global disability associated with intervertebral disc (IVD) pathologies. Discectomy alleviates disabling pain caused by IVD herniation without repairing annulus fibrosus (AF) defects, which can cause accelerated degeneration and recurrent pain. Biological therapies show promise for IVD repair but developing high-modulus biomaterials capable of providing biomechanical stabilisation and delivering biologics remains an unmet challenge. The present study identified critical factors and developed an optimal formulation to enhance the delivery of AF cells and transforming growth factor beta-3 (TGFβ−3) in genipin-crosslinked fibrin (FibGen) hydrogels. Part 1 showed that AF cells encapsulated in TGFβ−3-supplemented high-modulus FibGen synthesised little extracellular matrix (ECM) but could release TGFβ−3 at physiologically relevant levels. Part 2 showed that AF cells underwent apoptosis when encapsulated in FibGen, even after reducing fibrin concentration from 70 to 5 mg/mL. Mechanistic experiments, modifying genipin concentration and integrin binding site presence demonstrated that genipin crosslinking caused AF cell apoptosis by inhibiting cell-biomaterial binding. Adding integrin binding sites with fibronectin partially rescued apoptosis, indicating genipin also caused acute cytotoxicity. Part 3 showed that FibGen formulations with 1 mg/mL genipin had enhanced ECM synthesis when supplemented with fibronectin and TGFβ−3. In conclusion, FibGen could be used for delivering biologically active compounds and AF cells, provided that formulations supplied additional sites for cell-biomaterial binding and genipin concentrations were low. Results also highlighted a need for developing strategies that protect cells against acute crosslinker cytotoxicity to overcome challenges of engineering high-modulus cell carriers for musculoskeletal tissues that experience high mechanical demands. 2020-05-12 /pmc/articles/PMC7372750/ /pubmed/32396210 http://dx.doi.org/10.22203/eCM.v039a14 Text en Copyright policy: This article is distributed in accordance with Creative Commons Attribution Licence (http://creativecommons.org/licenses/by-sa/4.0/).
spellingShingle Article
Panebianco, C.J.
DiStefano, T.J.
Mui, B.
Hom, W.W.
Iatridis, J.C.
CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS
title CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS
title_full CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS
title_fullStr CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS
title_full_unstemmed CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS
title_short CROSSLINKER CONCENTRATION CONTROLS TGFβ−3 RELEASE AND ANNULUS FIBROSUS CELL APOPTOSIS IN GENIPIN-CROSSLINKED FIBRIN HYDROGELS
title_sort crosslinker concentration controls tgfβ−3 release and annulus fibrosus cell apoptosis in genipin-crosslinked fibrin hydrogels
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372750/
https://www.ncbi.nlm.nih.gov/pubmed/32396210
http://dx.doi.org/10.22203/eCM.v039a14
work_keys_str_mv AT panebiancocj crosslinkerconcentrationcontrolstgfb3releaseandannulusfibrosuscellapoptosisingenipincrosslinkedfibrinhydrogels
AT distefanotj crosslinkerconcentrationcontrolstgfb3releaseandannulusfibrosuscellapoptosisingenipincrosslinkedfibrinhydrogels
AT muib crosslinkerconcentrationcontrolstgfb3releaseandannulusfibrosuscellapoptosisingenipincrosslinkedfibrinhydrogels
AT homww crosslinkerconcentrationcontrolstgfb3releaseandannulusfibrosuscellapoptosisingenipincrosslinkedfibrinhydrogels
AT iatridisjc crosslinkerconcentrationcontrolstgfb3releaseandannulusfibrosuscellapoptosisingenipincrosslinkedfibrinhydrogels